The opioid epidemic and deaths from drug overdoses permeate daily news reports—and our daily lives, affecting patients, colleagues, acquaintances, or loved ones. In keeping with CO*RE’s educational mission, this page highlights current topics, compelling stories, and CO*RE outcomes to broaden awareness.
A growing list of entities—including private, state, and federal—are introducing prescription limit approaches as one tactic to combat the opioid epidemic. According to a press release on May 7, 2018, Walmart (and its membership-only warehouse Sam’s Club) pharmacies will soon “restrict initial acute opioid prescriptions to no more than [...]
On April 5, 2018, the U.S. Surgeon General issued the first public health advisory in 13 years. In short, he urges Americans to “Be prepared. Get naloxone. Save a life.” Naloxone is a potentially lifesaving medication that can temporarily reverse the effects of an opioid overdose. It is increasingly [...]
A recent CDC report examining emergency department data from July-September 2016 vs July-September 2017 shows a 30% increase in opioid overdose visits in the U.S. Such data can identify trends much sooner than waiting for data from death certificates. A closer analysis of 16 states that received funding to [...]
Federally, there are opioid policy declarations, funding allocations, commissions, and task forces. But states have purview over critical pieces of opioid policy impacting clinicians’ daily practice too. CO*RE maintains a State Information Hub providing speakers and learners attending live CO*RE activities with current individual state information on the following [...]
Despite having some of the world’s highest spending on medical care, a CDC report released in December showed that the U.S. experienced a decline in life expectancy for the second year in a row in 2016. The last time life expectancy dipped for one year was in 1993, during the [...]
In November 2017, the FDA released a report with analysis and recommendations for the use of continuing education (CE/CME) for Risk Evaluation and Mitigation Strategy (REMS). But what is a REMS? And how is healthcare provider CE/CME related to it? This new FDA Feasibility Report addresses these questions. A Risk [...]
On November 29, Attorney General Jeff Sessions announced three new initiatives from the Department of Justice to address the opioid crisis.First is the news of $12.2 million in federal grant funding for state and local law enforcement partners to combat illegal manufacturing and distribution of methamphetamine, heroin, and prescription opioids. [...]
A Dose of Insight, is the data-driven review of the state of medication-related errors and liability in American healthcare (by Robert Hansom, Maryann Small, and Ann Lambrecht, published by Coverys). This white paper provides insight into the root causes of medication-related claims based on an analysis of over 100,000 closed medical liability claims over a five year period...
The opioid crisis has touched all corners of our country, but the impact on our children is perhaps the most heartbreaking. Women using opioids during their pregnancy pass the drugs through the placenta and across the fetal blood-brain barrier. When birth abruptly shuts down the flow of the drug, the [...]
The White House continues to speak out on opioids. On October 26, 2017, the Trump Administration declared the opioid crisis a public health emergency. This declaration “will enable HHS to accelerate temporary appointments of specialized personnel to address the emergency (pending any funding needed); work with DEA to expand [...]